NCT03741231
- Conditions
- 18F-FDG, Immunotherapy, Melanoma, +13 more
- Locations
-
- CHRU de Brest Brest, France
- CH de LANDERNEAU Landerneau, France
- Centre Hospitalier de Morlaix Morlaix, France
Clinical trial condition
Explore clinical trials studying Positron-Emission Tomography. Study availability and eligibility vary by location and protocol.
NCT03741231
NCT03107663
NCT01035164
NCT01031199